Following up on CTLA-4 inhibition, Ruocco et al. found that a combination of anti-CTLA-4 therapy and radiation (which induced NKG2D ligands) resulted in the restoration of T-cell stopping and successful tumor treatment [33]. This evidence concerns the gene KLRK1 and neoplasm.